ViaDerma (ViaDerma) Change In Receivables : $1.52 Mil (TTM As of Jun. 2012)

View and export this data going back to 2008. Start your Free Trial

What is ViaDerma Change In Receivables?

ViaDerma's change in receivables for the quarter that ended in Jun. 2012 was $-0.82 Mil. It means ViaDerma's Accounts Receivable increased by $0.82 Mil from Mar. 2012 to Jun. 2012 .

ViaDerma's change in receivables for the fiscal year that ended in Dec. 2011 was $0.62 Mil. It means ViaDerma's Accounts Receivable declined by $0.62 Mil from Dec. 2010 to Dec. 2011 .

ViaDerma's Accounts Receivable for the quarter that ended in Jun. 2012 was $14.13 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. ViaDerma's Days Sales Outstanding for the three months ended in Jun. 2012 was 221.69.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. ViaDerma's liquidation value for the three months ended in Jun. 2012 was $1.36 Mil.

ViaDerma Change In Receivables Historical Data

The historical data trend for ViaDerma's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViaDerma Change In Receivables Chart

ViaDerma Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Change In Receivables

0.28

-2.53

0.09

0.62

ViaDerma Quarterly Data
	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12
Change In Receivables	Get a 7-Day Free Trial															-0.53	0.59	1.51	0.24	-0.82

ViaDerma Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2012 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.52 Mil.

ViaDerma (OTCPK:VDRM) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

ViaDerma's Days Sales Outstanding for the quarter that ended in Jun. 2012 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	14.132	/	5.817	*	91
=	221.69

2. In Ben Graham's calculation of liquidation value, ViaDerma's accounts receivable are only considered to be worth 75% of book value:

ViaDerma's liquidation value for the quarter that ended in Jun. 2012 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1.187	-	10.735	+	0.75 * 14.132	+	0.5 * 0.612
=	1.36

ViaDerma Change In Receivables Related Terms

Thank you for viewing the detailed overview of ViaDerma's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

ViaDerma (ViaDerma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ViaDerma Inc (OTCPK:VDRM) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292

Website

https://www.viaderma.com

ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.